Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
In alzheimer's disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial
(Cianfarani, 2019.) On the GH-IGF-1 axis and tumor growth GH controls IGF-1 production, which happens in the liver
WHERE TO CONNECT WITH ME: Follow Brandon on IG: Email: [email protected] For Info on Brandons Coaching Services: Brandons Website: My Reading Recommendations: THE MUSCLE & STRENGTH PYRAMIDS BODY RECOMP FOR HIGH PERFORMERS: MY COACHING FRAMEWORK FOR BUILDING MUSCLE & LOSING FAT SIMULTANEOUSLY | EP
[PMID: 24617525] PubMed record related to this compound for laboratory literature review
Quick Answer: Current limited evidence does not suggest GLP-1 agonists directly worsen Crohn's disease, but their gastrointestinal side effects may complicate symptom monitoring and disease assessment
